Zaprinast stimulates extracellular adenosine accumulation in rat pontine slices

Neuroscience Letters

Volumn 371, Issue 1, 2004, Pages 12-17

  Le, Minou ^a   Lu, Yin ^a   Li, Ya ^a   Greene, Robert W ^b   Epstein, Paul M ^c   Rosenberg, Paul A ^a  

^a Enders Research Building   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Adenosine; cAMP; cGMP; Cyclic nucleotide phosphodiesterase; Sleep; Zaprinast

Indexed keywords

3 ISOBUTYL 8 METHOXYMETHYL 1 METHYLXANTHINE; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 5' NUCLEOTIDASE; ADENOSINE; ADENOSINE PHOSPHATE; ALPHA BETA METHYLENE ADENOSINE DIPHOSPHATE; CYCLIC AMP; DIPYRIDAMOLE; DIZOCILPINE; EGTAZIC ACID; ENZYME INHIBITOR; ISOBUTYLMETHYLXANTHINE; PENTOSTATIN; SNAKE VENOM; UK 114542; UNCLASSIFIED DRUG; VERATRIDINE; ZAPRINAST;

ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR SPACE; NONHUMAN; PONS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; CYCLIC AMP; CYCLIC GMP; PHOSPHODIESTERASE INHIBITORS; PONS; PURINONES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 6944252488     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.07.090     Document Type: Article

References (43)

1. S.G. Andreeva, P. Dikkes, P.M. Epstein, and P.A. Rosenberg Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain J. Neurosci. 21 2001 9068 9076
2. J.A. Beavo, and D.H. Reifsnyder Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors Trends Pharmacol. Sci. 11 1990 150 155
3. A. Bonci, and J.T. Williams A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine Neuron 16 1996 631 639
4. C.L. Boulton, A.J. Irving, E. Southam, B. Potier, J. Garthwaite, and G.L. Collingridge The nitric oxide-cyclic GMP pathway and synaptic depression in rat hippocampal slices Eur. J. Neurosci. 6 1994 1528 1535
5. M.R. Broome, G.L. Collingridge, and A.J. Irving Activation of the NO-cGMP signalling pathway depresses hippocampal synaptic transmission through an adenosine receptor-dependent mechanism Neuropharmacology 33 1994 1511 1513
6. J.M. Brundege, L.H. Diao, W.R. Proctor, and T.V. Dunwiddie The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus Neuropharmacology 36 1997 1201 1210
7. O.H. Choi, M.T. Shamim, W.L. Padgett, and J.W. Daly Caffeine and theophylline analogs: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors Life Sci. 43 1988 387 398
8. T.M. Dawson, D.S. Bredt, M. Fotuhi, P.M. Hwang, and S.H. Snyder Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues Proc. Natl. Acad. Sci. U.S.A. 88 1991 7797 7801
9. T.V. Dunwiddie, and L. Diao Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses J. Pharmacol. Exp. Ther. 268 1994 537 545
10. D.A. Fisher, J.F. Smith, J.S. Pillar, S.H. St. Denis, and J.B. Cheng Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase J. Biol. Chem. 273 1998 15559 15564
11. R.W. Gereau, and P.J. Conn Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism Neuron 12 1994 1121 1129
12. E.F. Hearn, H.C.R. Grunze, D.G. Rainnie, P.A. Rosenberg, R.W. McCarley, and R.W. Greene Control of extracellular adenosine levels in the laterodorsal/pedunculopontine tegementum nuclei (LDT7PPT) Soc. Neurosci. Abstr. 21 1995 366
13. B.T. Hope, G.J. Michael, K.M. Knigge, and S.R. Vincent Neuronal NADPH diaphorase is a nitric oxide synthase Proc. Natl. Acad. Sci. U.S.A. 88 1991 2811 2814
14. J.-Y. Koh, and D.W. Choi Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase J. Neurosci. 8 1988 2153 2163
15. J. Kotera, N. Yanaka, K. Fujishige, Y. Imai, H. Akatsuka, T. Ishizuka, K. Kawashima, and K. Omori Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development Eur. J. Biochem. 249 1997 434 442
16. C.S. Leonard, and R. Llinas Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study Neuroscience 59 1994 309 330
17. Y. Li, H.J. Chung, X. Gan, R.W. Greene, and P.A. Rosenberg Zaprinast evokes extracellular adenosine accumulation in slices of the lateral dorsal tegmental nucleus Soc. Neurosci. Abstr. 23 1997 1782
18. Y. Lu, Y. Li, G.A. Herin, E. Aizenman, P.M. Epstein, and P.A. Rosenberg Elevation of intracellular cAMP evokes activity-dependent release of adenosine in cultured rat forebrain neurons Eur. J. Neurosci. 19 2004 2669 2681
19. W.F. MacDonald, and T.D. White Nature of extrasynaptosomal accumulation of endogenous adenosine evoked by K+ and veratridine J. Neurochem. 45 1985 791 797
20. O. Manzoni, D. Pujalte, J. Williams, and J. Bockaert Decreased presynaptic sensitivity to adenosine after cocaine withdrawal J. Neurosci. 18 1998 7996 8002
21. D.A. McCormick Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity Prog. Neurobiol. 39 1992 337 388
22. G. Moruzzi The sleep-waking cycle Ergebn. Physiol. 64 1972 1 165
23. D.E. Murphy, A.J. Hutchison, S.D. Hurt, M. Williams, and M.A. Sills Characterization of the binding of [3H]-CGS19755: a novel N-methyl-d-aspartate antagonist with nanomolar affinity in rat brain Br. J. Pharmacol. 95 1988 932 938
24. J.D. Pearson Ectonucleotidases. Measurement of activities and use of inhibitors D.M. Paton Methods in Pharmacology vol. 6 1987 Plenum Press New York 83 107
25. T. Porkka-Heiskanen, R.E. Strecker, M. Thakkar, A.A. Bjorkum, R.W. Greene, and R.W. McCarley Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness Science 276 1997 1265 1268
26. D.G. Rainnie, H.C.R. Grunze, R.W. McCarley, and R.W. Greene Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal Science 263 1994 689 692
27. P.A. Rosenberg Functional significance of cyclic AMP secretion in cerebral cortex Brain Res. Bull. 29 1992 315 318
28. P.A. Rosenberg, and M.A. Dichter Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture J. Neurosci. 9 1989 2654 2663
29. P.A. Rosenberg, and Y. Li Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by β3-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from cerebral cortex Brain Res. 692 1995 227 232
30. P.A. Rosenberg, and Y. Li Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture J. Neurosci. 14 1994 2953 2965
31. P.A. Rosenberg, and Y. Li Forskolin evokes extracellular adenosine accumulation in rat cortical cultures Neurosci. Lett. 211 1996 49 52
32. P.A. Rosenberg, and Y. Li Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures Neurosci. Lett. 200 1995 93 96
33. K. Semba, and H.C. Fibiger Organization of central cholinergic systems Prog. Brain Res. 79 1989 37 63
34. R.K. Sharma, A.M. Adachi, K. Adachi, and J.H. Wang Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies J. Biol. Chem. 259 1984 9248 9254
35. P. Skolnick, Y. Nimitkitpaisan, L. Stalvey, and J.W. Daly Inhibition of brain adenosine deaminase by 2′-deoxycoformycin and erythro-9-(2-hydroxy- 3-nonyl) adenine J. Neurochem. 30 1978 1579 1582
36. S.H. Snyder Adenosine as a neuromodulator W.M. Cowan E.M. Shooter C.F. Stevens R.F. Thompson Annual Review of Neuroscience vol. 8 1985 Annual Reviews, Inc. Palo Alto, CA 103 124
37. M. Steriade, S. Datta, D. Pare, G. Oakson, and R. Curro Dossi Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems J. Neurosci. 10 1990 2541 2559
38. M. Steriade, D. Pare, S. Datta, G. Oakson, and R. Curro Dossi Different cellular types in mesopontine cholinergic nuclei related to ponto-geniculo- occipital waves J. Neurosci. 10 1990 2560 2579
39. W.J. Thompson, W.L. Terasaki, P.M. Epstein, and S.J. Strada Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme Adv. Cyclic Nucleotide Res. 10 1979 69 92
40. J.A. Thorn, and S.M. Jarvis Adenosine transporters Gen. Pharmacol. 27 1996 613 620
41. D.G. Winder, P.S. Ritch, R.W. Gereau, and P.J. Conn Novel glial-neuronal signalling by coactivation of metabotropic glutamate and P-adrenergic receptors in rat hippocampus J. Physiol. (Lond.) 494 1996 743 755
42. E.H.G. Wong, J.A. Kemp, T. Priestley, A.R. Knight, G.N. Woodruff, and L.L. Iversen The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist Proc. Natl. Acad. Sci. U.S.A. 83 1986 7104 7108
43. K.A. Yamada, J.M. Dubinsky, and S.M. Rothman Quantitative physiological characterization of a quinoxalinedione non-NMDA antagonist J. Neurosci. 9 1989 3230 3236